Scott Clarke
Vorstandsvorsitzender bei Ambagon Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Scott Clarke
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation.
9
| Subsidiary | Biotechnology | 9 |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Ambagon Therapeutics, Inc.
 Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA.
8
| Holding Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Scott Clarke
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Imperial College London | College/University | Undergraduate Degree | |
| University of Aberdeen | College/University | Undergraduate Degree | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| University College London | College/University | Corporate Officer/Principal Doctorate Degree | |
| The Open University | College/University | Doctorate Degree | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor Private Equity Investor | |
Academy of Medical Sciences
 Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| European Molecular Biology Organization | Corporate Officer/Principal Corporate Officer/Principal | ||
Breakthrough Breast Cancer
 Breakthrough Breast Cancer Miscellaneous Commercial ServicesCommercial Services Part of Breast Cancer Campaign, Breakthrough Breast Cancer provides research and development services for breast cancer. The company is based in London, UK. The British company was founded in 1993. Breakthrough Breast Cancer was acquired by Breast Cancer Campaign on June 16, 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Gowrie Laxmico Ltd.
 Gowrie Laxmico Ltd. Medical DistributorsDistribution Services Gowrie Laxmico Ltd. distributes pharmaceutical products. The company was founded on October 8, 1997 and is headquartered in Middlesex, the United Kingdom. | Medical Distributors | Founder | |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Laxmi BNS Holdings Ltd.
 Laxmi BNS Holdings Ltd. Drugstore ChainsRetail Trade Founded in 2010, Laxmi BNS Holdings Ltd. is a pharmaceutical distribution and British sales company. The company is based in Ruislip, UK. | Drugstore Chains | Director/Board Member | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UCSF Helen Diller Family Comprehensive Cancer Center
 UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | Other Consumer Services | President | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Founder Director/Board Member Director/Board Member Director/Board Member | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director-Back Office Operation | |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Consultant / Advisor | |
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Syri Ltd. (United Kingdom)
 Syri Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Gowrie Holdings Ltd., Syri Ltd. is a British UK-based company founded in 2010. The company specializes in the development, licensing, manufacture, and marketing of liquid medicines. | Pharmaceuticals: Major | Director/Board Member | |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director-Back Office Operation | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
Laxmico Ltd.
 Laxmico Ltd. Medical DistributorsDistribution Services Part of Gowrie Laxmico Ltd., Laxmico is a wholesaler of pharmaceutical products. The company is based in Ruislip, UK. Laxmico was founded in 2009. | Medical Distributors | Director/Board Member | |
| Royal Free Hospital Medical School | College/University | Corporate Officer/Principal | |
The Institute of Cancer Research
 The Institute of Cancer Research Pharmaceuticals: MajorHealth Technology The Institute of Cancer Research studies the interplay of genes, proteins, and biological processes that drive the development, growth, and spread of cancers. The private company is based in London, UK. The British company focuses on identifying new treatment targets. | Pharmaceuticals: Major | Chief Executive Officer | |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member | |
| FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Founder Director of Finance/CFO | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Founder | |
| JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Gold Mast Consulting, LLC | Founder | ||
Sonata Therapeutics, Inc.
 Sonata Therapeutics, Inc. BiotechnologyHealth Technology Sonata Therapeutics, Inc. is a pioneering private company based in Cambridge, MA that designs single therapeutics to reprogram diseased cells and create curative microenvironments. The company's machine learning-based platform identifies novel insights, targets, and therapeutics across a wide range of disease areas, with a growing pipeline of small molecule drugs and genetic therapeutics. In oncology, Sonata's transformative therapies reprogram cancer cells to release curative signals that reverse immune cell suppression and blockade, empowering the immune system to holistically eradicate tumors and drive cure. Sonata Therapeutics is creating a new class of network medicines™ designed to modulate all the key cell types in a disease microenvironment required to drive disease resolution. The company is also exploring additional therapeutic areas such as fibrosis and tissue regeneration where multicellular networks play a key role. The company has subsidiaries in the United States. The company was founded in 2022 by flagship pioneering, and the CEO is Volker Herrmann. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 33 |
| Vereinigtes Königreich | 15 |
| Deutschland | 3 |
| Frankreich | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 13 |
| Finance | 8 |
| Commercial Services | 6 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 220 |
| Independent Dir/Board Member | 38 |
| Corporate Officer/Principal | 35 |
| Private Equity Investor | 26 |
| Founder | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nina Kjellson | 49 |
| Luke Evnin | 42 |
| Kurt von Emster | 34 |
| Shelley Chu | 31 |
| Roel Bulthuis | 29 |
| Michael Owen | 20 |
| John Hohneker | 19 |
| Anil Singhal | 18 |
| Margarita I. Chavez | 16 |
| Alan Ashworth | 14 |
| Adam Rosenberg | 13 |
| Scott Brun | 12 |
| Peter Dudek | 11 |
| Brian Silver | 8 |
| Seung Suh Hong | 7 |
- Börse
- Insiders
- Scott Clarke
- Unternehmensverbindungen
